34 results
CORRESP
LEGN
Legend Biotech Corp
8 Sep 23
Correspondence with SEC
12:00am
include China, Hong Kong, the British Virgin Islands, the United States and the European Union. Each of the Company’s foreign operating subsidiaries … Union own shares of the Company’s consolidated foreign operating subsidiaries in the respective jurisdictions.
With respect to the required disclosure
6-K
EX-99.1
LEGN
Legend Biotech Corp
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
, and applicable United States, European Union, Canadian and ICH Guidance, regulatory requirements for each Product, applicable USP, NF, JP and Ph. Eur … ” means any national (e.g., the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the European Agency
CORRESP
keo2fh xw8fk7v1l7
30 Sep 22
Correspondence with SEC
12:00am
6-K
EX-1.1
obe3cq4 2m8ilnfe5f
27 Jul 22
Announces Pricing of Public Offering
4:35pm
424B5
0iyc6w07v 3n42
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
aa6o3c 4ese6n
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.1
v60s rgjrlnt2kwj6lp
18 May 22
Legend Biotech Corp. 6-K
8:30am
6-K
EX-1.1
qip2c25mrrx jtw0
17 Dec 21
Announces Pricing of Public Offering
4:19pm
424B5
ob2sf79
17 Dec 21
Prospectus supplement for primary offering
4:16pm
424B5
ng2gqjnx
14 Dec 21
Prospectus supplement for primary offering
4:40pm
6-K
EX-99.3
7vvvf6dlcmanri060ra
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-99.2
30luai6xo9yv
13 Sep 21
Legend Biotech Corporation 6-K
9:02am
6-K
nipw hig1u4t
23 Aug 21
Current report (foreign)
8:16am
6-K
EX-99.1
cyc8l
22 Jun 21
Legend Biotech Announces Advancement of Global Manufacturing Infrastructure
8:00am
6-K
EX-99.2
0x706 fqc9re85k9sc
22 Jun 21
Legend Biotech Announces Advancement of Global Manufacturing Infrastructure
8:00am
6-K
EX-99.1
hd1wyjhiu2 599ea1r
9 Jun 21
Legend Biotech Corporation 6-K
8:00am